Found vs Oak
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Found and Oak are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Found starts lower at $169/mo versus $200/mo, and Found edges ahead overall (8.3 vs 8.1 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.
Pricing
Found
$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.
Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.
'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.
Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.
Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.
Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.
Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.
Oak
$200/month flat — one price at every dose, no subscription. Oak advertises 'from $119' but the terms behind it are quiz-gated and never published.
$250/month with $300 struck through, or $199 with code OAKSAVE200. Flat at every dose.
Get alerted when GLP-1 prices drop
Join the GLP-1 price-watch list — we re-verify 500+ providers' prices on their own sites and email you when tracked prices move.
What’s included
Found
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
Oak
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Included
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Found
8.3/10
Oak
8.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Found | Oak |
|---|---|---|
| Starting Price | ✓$169/mo | $200/mo |
| Features | 3 features | ✓4 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Found
Personalized weight care platform with a self-pay membership model plus medication costs.
Read our full Found review →About Oak
Telehealth provider offering compounded GLP-1 medications (semaglutide and tirzepatide) operated by Oak Longevity Holdings Corp. with prescriptions issued through NVP Medical Group, P.A.
Read our full Oak review →Pros & Cons
Found
What we like
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Oak
What we like
- Both compounded semaglutide ($119/mo) and tirzepatide ($185/mo) on a single platform
- $200-off new-patient offer advertised — final discounted price is shown after the intake quiz
- LegitScript-certified pharmacy network
- No video call required for initial approval; flat per-month pricing across all dose strengths
Watch-outs
- Pharmacy partners are not publicly named on the marketing site (material gap for YMYL disclosure)
- Operates in 45 states per Terms of Use, but the public state list is gated behind the signup intake
- No brand-name Wegovy / Zepbound / Mounjaro / Ozempic available — compounded only
- Fees are non-refundable per Terms of Use; binding arbitration under Delaware law
Our Verdict
Found edges out Oak with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. Oak remains a solid alternative, especially if you're looking for compounded semaglutide and tirzepatide at a flat monthly price.
Choose Found if…
You want mainstream telehealth GLP-1 access and a starting price around $169/mo.
Choose Oak if…
You want compounded semaglutide and tirzepatide at a flat monthly price and a starting price around $200/mo.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Trimi Health
Budget-conscious shoppers
From $99/mo
Get started →ShedRx
Mainstream telehealth GLP-1 access
From $149/mo
Get started →bmiMD
Mainstream telehealth GLP-1 access
From $99/mo
Get started →Found vs Oak: FAQ
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Found and Oak head-to-heads in the same category.
- Found vs Amazon One Medical
- Found vs Vytora Health
- Found vs Collective
- Oak vs CoreAge Rx
- Oak vs EverSlim
- Oak vs NewSelf
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.